Avadel Pharmaceuticals
AVDL
#5137
Rank
โ‚ฌ1.19 B
Marketcap
12,38ย โ‚ฌ
Share price
-19.33%
Change (1 day)
23.27%
Change (1 year)

Revenue for Avadel Pharmaceuticals (AVDL)

Revenue in 2024 (TTM): โ‚ฌ88.1 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ89.61 Million. In 2023 the company made a revenue of โ‚ฌ25.29 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avadel Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ88.1 M248.31%
2023 โ‚ฌ25.29 M
2022 N/A
2021 N/A-100%
2020 โ‚ฌ18.15 M-65.65%
2019 โ‚ฌ52.85 M-41.44%
2018 โ‚ฌ90.27 M-37.48%
2017 โ‚ฌ0.14 B1.08%
2016 โ‚ฌ0.14 B-9.2%
2015 โ‚ฌ0.15 B2882.98%
2014 โ‚ฌ5.27 M-67.55%
2013 โ‚ฌ16.25 M-17.64%
2012 โ‚ฌ19.73 M-21.4%
2011 โ‚ฌ25.1 M-9.99%
2010 โ‚ฌ27.88 M-5.14%
2009 โ‚ฌ29.39 M6.42%
2008 โ‚ฌ27.62 M10.04%
2007 โ‚ฌ25.1 M43.89%
2006 โ‚ฌ17.44 M-12.42%
2005 โ‚ฌ19.92 M-60.7%
2004 โ‚ฌ50.68 M157.32%
2003 โ‚ฌ19.69 M12.15%
2002 โ‚ฌ17.56 M18.53%
2001 โ‚ฌ14.81 M30.15%
2000 โ‚ฌ11.38 M3.76%
1999 โ‚ฌ10.97 M36.75%
1998 โ‚ฌ8.02 M19.03%
1997 โ‚ฌ6.74 M63.27%
1996 โ‚ฌ4.12 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.21 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.67 B 652.89%๐Ÿ‡บ๐Ÿ‡ธ USA